Alar Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|
| ALA-3000 | Treatment‑Resistant Depression | Phase 1 |
| ALA-1000 | Osteoarthritis‑Associated Pain (Veterinary) | Animal Drug |
| ALA-1300 | CNS Disorder (Preclinical) | Preclinical |
| ALA-2000 | CNS Disorder (Preclinical) | Preclinical |
| Bupanlar | Long‑Acting Osteoarthritis Analgesic (Veterinary) | Animal Drug |